GV20 Therapeutics

GV20 Therapeutics is a developer of medical biotechnology aimed at customizing cancer treatments. The company focuses on utilizing gene editing and bioinformatics technologies to identify therapeutic targets for cancer and develop corresponding treatment strategies, providing enhanced treatment options for cancer patients and enabling the early detection of tumors.